We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Texas Capital Bancshares
TCBI
$4.32B
| $11.9M | ﹤0.01% |
201,391
-16,033
| -7% | -$950K |
|
1352
Central Pacific Financial
CPF
$1B
| $11.9M | ﹤0.01% |
574,266
+22,904
| +4% | +$516K |
|
1353
CTS Corp
CTS
$1.89B
| $11.9M | ﹤0.01% |
285,136
+16,306
| +6% | +$655K |
|
1354
Fox Class B
FOX
$23.9B
| $11.9M | ﹤0.01% |
416,700
-18,046
| -4% | -$566K |
|
1355
Grupo Aeroportuario Centro Norte
OMAB
$5.33B
| $11.9M | ﹤0.01% |
236,777
-27,194
| -10% | -$1.43M |
|
|
X
1356
DELISTED
US Steel
X
| $11.9M | ﹤0.01% |
654,636
-248,004
| -27% | -$5.3M |
|
|
KZR
1357
DELISTED
Kezar Life Sciences
KZR
| $11.9M | ﹤0.01% |
137,730
+80,054
| +139% | +$7.78M |
|
1358
Cannae Holdings
CNNE
$649M
| $11.9M | ﹤0.01% |
573,896
+159,674
| +39% | +$3.44M |
|
1359
Stepan Co
SCL
$1.48B
| $11.9M | ﹤0.01% |
126,549
-1,203
| -0.9% | -$125K |
|
1360
SLM Corp
SLM
$5.15B
| $11.8M | ﹤0.01% |
846,549
-50,457
| -6% | -$782K |
|
|
FOLD
1361
DELISTED
Amicus Therapeutics
FOLD
| $11.8M | ﹤0.01% |
1,130,735
-131,828
| -10% | -$1.47M |
|
1362
H.B. Fuller
FUL
$3.28B
| $11.8M | ﹤0.01% |
195,733
+26,854
| +16% | +$1.71M |
|
1363
Landstar System
LSTR
$6.21B
| $11.8M | ﹤0.01% |
81,467
-1,380
| -2% | -$206K |
|
1364
CNO Financial Group
CNO
$5.1B
| $11.8M | ﹤0.01% |
654,271
+84,551
| +15% | +$1.57M |
|
|
NVEE
1365
DELISTED
NV5 Global
NVEE
| $11.7M | ﹤0.01% |
379,240
+64,868
| +21% | +$2.12M |
|
1366
Rayonier
RYN
$6.55B
| $11.7M | ﹤0.01% |
431,141
-8,760
| -2% | -$283K |
|
1367
RLI Corp
RLI
$5.89B
| $11.7M | ﹤0.01% |
228,878
-2,094
| -0.9% | -$117K |
|
1368
Amphastar Pharmaceuticals
AMPH
$916M
| $11.7M | ﹤0.01% |
416,607
-174,217
| -29% | -$5.69M |
|
1369
MP Materials
MP
$9.1B
| $11.7M | ﹤0.01% |
427,197
+203,527
| +91% | +$6.65M |
|
1370
BGC Group
BGC
$4.89B
| $11.6M | ﹤0.01% |
3,704,355
+60,593
| +2% | +$235K |
|
1371
Knowles
KN
$3.34B
| $11.6M | ﹤0.01% |
955,503
+4,637
| +0.5% | +$74.3K |
|
1372
Virtu Financial
VIRT
$4.93B
| $11.6M | ﹤0.01% |
559,693
+191,288
| +52% | +$4.39M |
|
1373
ManpowerGroup
MAN
$2.63B
| $11.6M | ﹤0.01% |
179,362
-28,301
| -14% | -$2.13M |
|
1374
ATI
ATI
$31B
| $11.6M | ﹤0.01% |
435,774
+58,317
| +15% | +$1.62M |
|
1375
Gogo Inc
GOGO
$492M
| $11.6M | ﹤0.01% |
956,736
-149,637
| -14% | -$2.27M |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.